326 related articles for article (PubMed ID: 11067900)
1. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
2. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow cell transfer of autoimmune diseases in a MRL strain of mice with a deficit in functional Fas ligand: dissociation of arteritis from glomerulonephritis.
Ito MR; Ono M; Itoh J; Nose M
Pathol Int; 2003 Aug; 53(8):518-24. PubMed ID: 12895230
[TBL] [Abstract][Full Text] [Related]
4. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
6. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.
Silver PB; Agarwal RK; Su SB; Suffia I; Grajewski RS; Luger D; Chan CC; Mahdi RM; Nickerson JM; Caspi RR
J Immunol; 2007 Oct; 179(8):5146-58. PubMed ID: 17911600
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity in mice bearing lprcg: a novel mutant gene.
Kimura M; Matsuzawa A
Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
10. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
[TBL] [Abstract][Full Text] [Related]
11. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Chu JL; Ramos P; Rosendorff A; Nikolić-Zugić J; Lacy E; Matsuzawa A; Elkon KB
J Exp Med; 1995 Jan; 181(1):393-8. PubMed ID: 7528774
[TBL] [Abstract][Full Text] [Related]
12. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of apoptotic cells in experimental autoimmune uveoretinitis.
Sueda J; Hikita N; Mochizuki M; Jimi A; Kojiro M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):799-804. PubMed ID: 10711696
[TBL] [Abstract][Full Text] [Related]
14. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody.
Namba K; Ogasawara K; Kitaichi N; Morohashi T; Sasamoto Y; Kotake S; Matsuda H; Iwabuchi K; Iwabuchi C; Ohno S; Onoé K
J Immunol; 2000 Sep; 165(6):2962-9. PubMed ID: 10975803
[TBL] [Abstract][Full Text] [Related]
16. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
Huber S; Shi C; Budd RC
J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
[TBL] [Abstract][Full Text] [Related]
17. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.
Jiang G; Wang Y; Yun J; Hajrasouliha AR; Zhao Y; Sun D; Kaplan HJ; Shao H
J Neuroinflammation; 2015 Sep; 12():179. PubMed ID: 26394985
[TBL] [Abstract][Full Text] [Related]
19. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis.
Waldner H; Sobel RA; Howard E; Kuchroo VK
J Immunol; 1997 Oct; 159(7):3100-3. PubMed ID: 9317104
[TBL] [Abstract][Full Text] [Related]
20. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Mittelstadt PR; Ashwell JD
J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
